Sarah Gheuens, Chief Medical Officer at AGIOS PHARMACEUTICALS, INC. (AGIO), sold 4,908 shares at $43.78 ($215K) on 2025-11-11, disclosed to the SEC on 2025-11-13.
Scheduled sale ($215k) by Chief Medical Officer under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $43.78 | 2,454 | $107K | 50.0% |
| 2 | $43.78 | 2,454 | $107K | 50.0% |
| Total | $43.78 avg | 4,908 | $215K | 100% |
| Filing → |
| AGIO | SELL | 2026-04-06 | $102K | — | Filing → |
| AGIO | SELL | 2026-03-03 | $83K | — | Filing → |
| AGIO | SELL | 2026-01-02 | $79K | — | Filing → |